» Articles » PMID: 25239901

Microbiota in the Throat and Risk Factors for Laryngeal Carcinoma

Overview
Date 2014 Sep 21
PMID 25239901
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The compositions and abundances of the microbiota in the ecological niche of the human throat and the possible relationship between the microbiota and laryngeal cancer are poorly understood. To obtain insight into this, we enrolled 27 laryngeal carcinoma patients and 28 subjects with vocal cord polyps as controls. For each subject, we simultaneously collected swab samples from the upper throat near the epiglottis (site I) and tissue samples from the vestibulum laryngis to the subglottic region (site II). The microbiota of the throat were fully characterized by pyrosequencing of barcoded 16S rRNA genes. We found 14 phyla, 20 classes, 38 orders, 85 families, and 218 genera in the throats of enrolled subjects. The main phyla were Firmicutes (54.7%), Fusobacteria (14.8%), Bacteroidetes (12.7%), and Proteobacteria (10.6%). Streptococcus (37.3%), Fusobacterium (11.3%), and Prevotella (10.6%) were identified as the three most predominant genera in the throat. The relative abundances of 23 bacterial genera in site I were significantly different from those in site II (P < 0.05). The relative proportions of 12 genera largely varied between laryngeal cancer patients and control subjects (P < 0.05). Collectively, this study outlined the spatial structure of microbial communities in the human throat. The spatial structure of bacterial communities significantly varied in two anatomical sites of the throat. The bacterial profiles of the throat of laryngeal cancer patients were strongly different from those of control subjects, and several of these microorganisms may be related to laryngeal carcinoma.

Citing Articles

Intra-tumoral bacteria in head and neck cancer: holistic integrative insight.

Meng Y, Deng J, Deng W, Sun Z Cancer Biol Med. 2025; 22(2).

PMID: 39969204 PMC: 11899592. DOI: 10.20892/j.issn.2095-3941.2024.0311.


Oral microbiota: the overlooked catalyst in cancer initiation and progression.

Wang X, He X, Zhong B Front Cell Dev Biol. 2025; 12:1479720.

PMID: 39872848 PMC: 11769975. DOI: 10.3389/fcell.2024.1479720.


Assessing the oral microbiome of head and neck cancer patients before and during radiotherapy.

de Freitas Neiva Lessa A, da Silva Amancio A, de Oliveira A, de Sousa S, Caldeira P, de Aguiar M Support Care Cancer. 2024; 32(11):752.

PMID: 39470839 DOI: 10.1007/s00520-024-08953-x.


Cancer invasion and anaerobic bacteria: new insights into mechanisms.

Hurst R, Brewer D, Gihawi A, Wain J, Cooper C J Med Microbiol. 2024; 73(3).

PMID: 38535967 PMC: 10995961. DOI: 10.1099/jmm.0.001817.


Fecal and oral microbiome analysis of snakes from China reveals a novel natural emerging disease reservoir.

Hu X, Yang L, Zhang Y, Yang M, Li J, Fan Y Front Microbiol. 2024; 14:1339188.

PMID: 38274764 PMC: 10808610. DOI: 10.3389/fmicb.2023.1339188.


References
1.
Ramroth H, Schoeps A, Rudolph E, Dyckhoff G, Plinkert P, Lippert B . Factors predicting survival after diagnosis of laryngeal cancer. Oral Oncol. 2011; 47(12):1154-8. DOI: 10.1016/j.oraloncology.2011.08.003. View

2.
Wang Q, Garrity G, Tiedje J, Cole J . Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007; 73(16):5261-7. PMC: 1950982. DOI: 10.1128/AEM.00062-07. View

3.
Hendrickson E, Wang T, Dickinson B, Whitmore S, Wright C, Lamont R . Proteomics of Streptococcus gordonii within a model developing oral microbial community. BMC Microbiol. 2012; 12:211. PMC: 3534352. DOI: 10.1186/1471-2180-12-211. View

4.
James W, Garza C . Summary of the 24(th) Marabou Symposium: Nutrition and the human microbiome. Nutr Rev. 2012; 70 Suppl 1:S87-94. DOI: 10.1111/j.1753-4887.2012.00497.x. View

5.
Price K, Cohen E . Current treatment options for metastatic head and neck cancer. Curr Treat Options Oncol. 2012; 13(1):35-46. DOI: 10.1007/s11864-011-0176-y. View